Optimal maturation of oocytes and successful development of preimplantation embryos is essential for reproduction. We performed DNA microarray analyses of ovarian transcripts and identified glial cell line-derived neurotrophic factor (GDNF) secreted by cumulus, granulosa, and theca cells as an ovarian factor stimulated by the preovulatory LH/hCG surge. Treatment of cumulus-oocyte complexes with GDNF enhanced first polar body extrusion with increase in cyclin B1 synthesis and the GDNF actions are likely mediated by its receptor GDNF family receptoralpha1 (GFRA1) and a co-receptor ret proto-oncogene (Ret), both expressed in oocytes. However, treatment with GDNF did not affect germinal vesicle breakdown and cytoplasmic maturation of oocytes. During the preimplantation stages, GDNF was expressed in pregnant oviducts and uteri, whereas GFRA1 and Ret were expressed in embryos throughout early development with an increase after the early blastocyst stage. In blastocysts, both GDNF and GFRA1 were exclusively localized in trophectoderm cells, whereas Ret was detected in both cell lineages. Treatment with GDNF promoted the development of two-cell-stage embryos into blastocysts showing increased cell proliferation and decreased apoptosis mainly in trophectoderm cells. Our findings suggest potential paracrine roles of GDNF in the promotion of completion of meiosis I and the development of early embryos.
Introduction
In vertebrates, rupture of ovarian follicles and final maturation of oocytes for fertilization occur in response to stimulation by pituitary-derived LH that acts on the somatic granulosa and theca cells surrounding the oocyte. Shortly after stimulation by the preovulatory surge of LH, oocytes arrested at the late prophase I resume meiosis characterized by germinal vesicle (nuclear envelope) breakdown (GVBD), chromosome condensation, and extrusion of the first polar body in preparation for fertilization and early embryonic development. Recent studies demonstrated that the endocrine hormone LH stimulates ovarian production of epidermal growth factor (EGF)-like factors from granulosa cells and insulin-like 3 (INSL3) from theca cells to promote GVBD (Kawamura et al., 2004; Park et al., 2004) . In addition to nuclear maturation exemplified by GVBD and extrusion of the first polar body to complete the first meiotic division, oocytes also undergo cytoplasmic maturation characterized by cytoplasmic changes essential for monospermic fertilization, processing of the sperm, and preparation for development to preimplantation embryos (Eppig, 1996; Fulka et al., 1998) . Preovulatory increases in LH also stimulate granulosa cells to produce brain-derived neurotrophic factor (BDNF) that is capable of promoting first polar body extrusion and the cytoplasmic maturation of oocytes (Kawamura et al., 2005c) . After the conditioning of the oocyte in preparation for fertilization and preimplantation development by ovarian factors, a number of growth factors and cytokines further act as paracrine and/or autocrine factors during early embryonic development (Brison and Schultz, 1998; Dey et al., 2004; Hardy and Spanos, 2002) .
We performed DNA microarray analyses using ovaries following gonadotropin stimulation and identified candidate ligand-receptor pairs potentially involved in the process of oocyte maturation (Kawamura et al., 2005c) . Among different candidate genes, we found major increases in the ovarian expression of glial cell line-derived neurotrophic factor (GDNF) during the preovulatory period. GDNF was first identified as a survival factor for several types of neurons (Airaksinen and Saarma, 2002; Lin et al., 1993) . GDNF acts through a twocomponent receptor system consisting of the ligand-specific binding subunit, GDNF family receptor-alpha1 (GFRA1) and the common signal transduction subunit, ret proto-oncogene (Ret) (Saarma and Sariola, 1999) . Although GDNF and its receptor system are expressed in the nervous system, their expression has also been detected in several peripheral tissues, including ovary and testis (Trupp et al., 1995) . In the testis, GDNF contributes to paracrine regulation of spermatogonial self-renewal and differentiation (Meng et al., 2000) and acts as the primary growth factor supporting self-renewal of spermatogonial stem cells in mice (Brinster, 2007) . However, few studies have explored the roles of GDNF in oocyte maturation and early embryonic development.
Here, we demonstrated the preovulatory increases of GDNF transcripts and proteins in ovarian cumulus, granulosa, and theca cells, and the expression of its receptors, GFRA1 and Ret, in mouse oocytes. Treatment of cultured oocytes with GDNF enhanced first polar body extrusion, but not GVBD and the competence of oocytes to complete preimplantation development. We also demonstrated the expression of GDNF, GFRA1, and Ret in preimplantation embryos and pregnant oviducts and uteri of mice. Treatment of cultured two-cell-stage embryos with GDNF promoted their development to blastocysts characterized by the suppression of apoptosis of preimplantation embryos.
Materials and methods

Animals
Ovarian samples were obtained from female B6D2F1 mice at 25 days of age (CLEA Japan, Tokyo, Japan) during treatment with a single i.p. injection of 7 IU of pregnant mare serum gonadotropin (PMSG; Calbiochem, Cambridge, MA) followed at 48 h later with 10 IU of human chorionic gonadotropin (hCG; ASKA Pharmaceutical, Tokyo, Japan) administrated i.p. To obtain preimplantation embryos, B6D2F1 mice treated sequentially with PMSG and hCG were allowed to mate immediately after hCG treatment. At 46-47 h after hCG injection, two-cell-stage embryos were obtained by flushing the oviducts of mated mice for in vitro culture as described (Kawamura et al., 2005a) . Oviducts and uteri were obtained from immature untreated mice, mice treated with PMSG (7 IU), mice treated with PMSG followed 12 h later by hCG (10 IU) treatment, and from animals at 2 and 4 days after mating. The care and use of animals was approved by the Animal Research Committee, Akita University School of Medicine.
DNA microarray analyses
Female B6D2F1 mice (n = 108) were injected at 21 days of age with Humegon (7.5 IU per animal, Organon, Oss, Netherlands) containing folliclestimulating hormone and LH activities to stimulate follicular growth. Fortyeight hours later, some animals were treated i.p. with Pregnyl (5 IU per animal, Organon) containing LH activity to induce ovulation. Ovaries were dissected from animals killed bi-hourly after Humegon treatment (three mice per group) and hourly after Pregnyl treatment (one mouse per group) for RNA extraction (TRIzol; Invitrogen, Carlsbad, CA). Aliquots of 6 μg of total RNA at 1 μg/μl for one-chipset hybridization were stored at −80°C. Samples were hybridized to the Affymetrix mouse MGU74v2 arrays A, B, and C (Affymetrix, Santa Clara, CA) according to standard Affymetrix protocols. The pooled follicular phase samples were hybridized in duplicate, and the post Pregnyl samples were single determinations (Kawamura et al., 2005c) .
RT-PCR
For quantitative real-time RT-PCR, germinal vesicle (GV) stage oocytes, cumulus cells, and mural granulosa cells were collected from ovaries of PMSG-treated immature mice at 48 h after treatment (Kawamura et al., 2005c) . Cumulus-oocyte complexes (COCs) were obtained by puncturing the largest follicles of preovulatory ovaries, and denuded oocytes (DOs) were separated from cumulus cells by mechanical pipetting. Granulosa cells were obtained separately by puncturing preovulatory follicles, followed by the removal of COCs. Two-cell-stage embryos were obtained by flushing the oviducts of mated mice at 46-47 h after hCG injection for in vitro culture as described (Kawamura et al., 2005a) . Embryos were allowed to continue development to different stages and were then collected after culturing in individual microdrops for 50-52 h (four-cell), 59-60 h (eight-cell), 70-72 h (morula), 94-96 h (early blastocyst), 119-120 h (expanded blastocyst), and 142-144 h (hatched blastocyst) after hCG injection.
Quantitative real-time RT-PCR of transcript levels in ovarian cells, preimplantation embryos, whole ovaries, oviducts, and uteri was performed using a SmartCycler (Takara, Tokyo, Japan) (Kawamura et al., 2005a (Kawamura et al., ,c, 2007 . The primers and hybridization probes for real-time RT-PCR of Gdnf, Gfra1, Ret, and histoneH2a are as follows: Gdnf: sense 5′-CCAGA-GACTGCTGTGTATTGC-3′, antisense 5′-GGTGGCTACCTTCCTCCTTC-3′, probe 5′-6-carboxy-fluorescein (FAM)-GGCGGAGGCAGAGGCAGAA-GAAGAG-6-carboxy-tetramethyl-rhodamine (TAMRA)-3′; Gfra1: sense 5′-CAGATCTCGCCTTGCAGATT-3′, antisense 5′-GGAGGCAGTCTGCG-TAGTTC-3′, probe 5′-FAM-TTACCAACTGCCAGCCAGAGTCAAG-TAMRA-3′; Ret: sense 5′-TGGCACACCTCTGCTCTATG-3′, antisense 5′-GATGCGGATCCAGTCATTCT-3′, probe 5′-FAM-TCTCTATGGCGTC-TACCGTACACGG-TAMRA-3′; histone H2a: sense 5′-ACGAGGAGCT-CAACAAGCTG-3′, antisense 5′-TATGGTGGCTCTCCGTCTTC-3′, probe 5′-FAM-AACATCCAGGCCGTGCTGCT-TAMRA-3′. To determine the absolute copy number of target transcripts, cloned plasmid cDNAs for individual gene were used to generate a calibration curve. Purified plasmid cDNA templates were measured, and copy numbers were calculated based on absorbance at 260 nm. A calibration curve was created by plotting the threshold cycle against the known copy number for each plasmid template diluted in log steps from 10 5 to 10 1 copies. Each run included standards of diluted plasmids to generate a calibration curve, a negative control without a template, and samples with unknown mRNA concentrations. Data were normalized based on histone H2a transcript levels (Robert et al., 2002) .
For conventional RT-PCR to study cell types expressing specific genes, primers for β-actin were used as described (Kawamura et al., 2003) . PCR reactions comprised of 35-40 cycles of amplification with denaturation at 94°C for 30 s, annealing at 60°C for 30 s, and elongation at 72°C for 30 s. For positive controls, mouse ovary cDNA was amplified. For negative controls, no mRNA was included.
Isolation of inner cell mass and trophectoderm cells
Inner cell mass and trophectoderm cells were isolated by immunosurgery as described (Kawamura et al., 2005a) . After zona removal and lysis using acid Tyrode's solution (Sigma, St. Louis, MO), blastocysts were incubated sequentially at 37°C in rabbit anti-mouse serum (Sigma) diluted 1:10 in M2 medium (Sigma) for 10 min and then in guinea pig complement serum (Sigma) diluted 1:3 in M2 medium with 10% fetal bovine serum (FBS) for 30 min. The lysed trophectoderm cell fraction was subjected to RNA extraction. To remove residual trophectoderm cells, the inner cell mass was washed through small-bore glass pipettes before RNA extraction. A total of 15-20 blastocysts was used to isolate each cell fraction, and total RNA was extracted using a RNeasy Micro kit (QIAGEN, Tokyo, Japan) before RT-PCR to determine the spatial expression of Gdnf, Gfra1, and Ret in the blastocysts. To confirm purity of specific cell preparations, RT-PCR was performed to detect the inner cell mass marker, Oct-4 (Palmieri et al., 1994) and the trophectoderm marker, urokinase plasminogen activator (uPA) (Robertson et al., 2001 ).
ELISA and immunohistochemistry
For ELISA, mouse ovaries were homogenized in a buffer containing 137 mM NaCl, 20 mM Tris-HCl, 1% Nonidet P40, 10% glycerol, and a protease inhibitor cocktail (Roche Applied Science, Indianapolis, IN) before centrifugation at 8000×g for 5 min at 4°C. The supernatant was removed and stored at − 80°C until use. Levels of GDNF were quantified using the GDNF Emax immunoassay system (Promega, Madison, WI) after sample thawing and centrifugation at 8000×g for 5 min at 4°C. The supernatant was diluted 1:4 in PBS for protein determination using the DC Protein Assay kit (BioRad, Hercules, CA). The GDNF ELISA was performed by using 96-well plates coated with a mouse monoclonal anti-GDNF antibody as a capture antibody. A chicken anti-human GDNF polyclonal antibody was used as the primary antibody. The sandwich complex was detected by using an antichicken IgY-horseradish peroxidase conjugate, and tetramethylbenzidine was used as the substrate for colorimetric analysis. The reaction was stopped with 1 M HCl before measuring the absorbance at 450 nm. The results were normalized by protein concentrations and expressed as pg of GDNF per mg of ovary.
To localize GDNF, ovaries were obtained from PMSG-primed mice at 4 h after hCG injection, whereas oviducts and uteri were obtained from pregnant mice at 4 days after mating. After fixation with Bouin's solution for 1 h at room temperature before transfer to 70% ethanol, tissues were embedded in paraffin and sectioned at 3-μm intervals. After deparaffinization and dehydration, slides were subjected to antigen retrieval with microwave heating in 10 mM citrate buffer (pH 6) for 5 × 3 min. Endogenous peroxidase activities were quenched with 0.3% hydrogen peroxidase-methanol for 30 min. After blocking with 10% bovine serum albumin (BSA)-PBS for 30 min, slides were incubated with rabbit anti-GDNF polyclonal antibodies (Abcam, Cambridge, UK) at 1:100 dilution overnight at 4°C. After three washes in Tris-buffered saline (TBS), slides were incubated with biotinylated anti-rabbit secondary antibodies (Zymed Laboratories, San Francisco, CA) for 30 min at room temperature. After three washes, bound antibodies were visualized using a Histostain SP kit (Zymed Laboratories). For negative controls, the primary antibody was replaced by nonimmune rabbit IgG (Dako, Carpinteria, CA).
Immunostaining of GDNF was performed using mouse blastocysts as described (Li et al., 2005) . Embryos were fixed with 4% paraformaldehyde (Electro Microscopy Sciences, PA) and then permeabilized in PBS with 0.1% Triton X-100 (Sigma) for 10 min at room temperature. After blocking with Image-iT FX signal enhancer (Invitrogen), embryos were incubated with the anti-GDNF antibodies in 1% BSA-PBS at 1:100 dilution overnight at 4C. After three washes in 1% BSA-PBS, embryos were incubated with Alexa Flour-488 donkey anti-rabbit IgG (Invitrogen) in 1% BSA-PBS at 1:1,000 dilutions for 1 h at room temperature followed by three additional washes. Counterstaining was performed for 30 min using 1 μg/ml of Hoechst 33342 dye (Invitrogen). After five washes in PBS, embryos were analyzed under a confocal laser-scanning microscope (SP2 AOBS, Leica, Wetzlar, Germany). For negative controls, the primary antibody was replaced by nonimmune rabbit IgG (Alpha diagnostic Intl, San Antonio, TX).
Follicle cultures
Preovulatory follicles were excised from mouse ovaries at 48 h after PMSG treatment and cultured to examine nuclear maturation of oocytes (Kawamura et al., 2004) . Follicles (20-30 per vial) were treated with or without recombinant human GDNF (Pepro-Tech, Rocky Hill, NJ) or 5 μg/ml LH (Organon, Oss, Netherlands) in Leibovitz's L-15 medium (Invitrogen). The doses of GDNF chosen for these experiments were based on the results of COC model described below. The vials were flushed at the start of the culture with O 2 /N 2 (at a 1:1 ratio), sealed, and cultured at 37°C with gentle shaking for 8 h. After culture, COCs were isolated, and, after cumulus cell removal, oocytes were examined for the occurrence of GVBD under a Hoffman modulation contrast microscopy (Nikon Inc., Tokyo, Japan).
Evaluation of first polar body extrusion
Either COCs or DOs were cultured with or without GDNF to evaluate the effect of GDNF on the transition from metaphase I stage to metaphase II (MII) stage oocytes. The doses of GDNF chosen for the present studies were based on the levels of GDNF found in human follicular fluid (0.4-10.8 ng/ml, Kawamura et al., unpublished data) and those of other ovarian paracrine factors used in oocyte maturation studies (Kawamura et al., 2005c; Park et al., 2004) . COCs and DOs were obtained from mouse ovaries at 48 h after PMSG treatment as described above. After washing, COCs or DOs were transferred to M16 medium (Sigma) without FBS, and cultured with or without GDNF for 24 h at 37°C in 5% CO 2 /95% air. Some COCs were also cultured with or without GDNF in the absence or presence of a neutralizing anti-GDNF antibody (R&D Systems, Minneapolis, MN) or nonimmune goat IgG (Dako). In addition, some COCs were cultured without or with 30 ng/ml GDNF, 3 ng/ml BDNF or 30 ng/ml GDNF in the presence of 3 ng/ml BDNF (Kawamura et al., 2005c) . The occurrence of first polar body extrusion in the oocyte was examined after removing cumulus cells by using a small-bore pipette.
COC cultures and immunoblotting analyses
COCs were cultured with or without GDNF to measure the levels of cyclin B1 in oocytes by immunoblotting. COCs were obtained from mouse ovaries at 48 h after PMSG treatment and cultured with or without 30 ng/ml GDNF as described above. After 7 h of treatment, cumulus cells were removed and the metaphase I (MI) oocytes were collected for immunoblotting (Kawamura et al., 2000) . Fifty oocytes were homogenized in a buffer containing 137 mM NaCl, 20 mM Tris-HCl, 1% Nonidet P40, 10% glycerol, and a protease inhibitor cocktail. Samples were boiled for 3 min, and separated by electrophoresis under reducing conditions on 10% polyacrylamide gels and transferred to polyvinylidene difluoride membranes pre-incubated for 1 h in blocking buffer containing 5% nonfat dry milk. The membranes were incubated with anti-cyclin B1 monoclonal antibodies (Cell Signaling Technology, Danvers, MA) overnight at 4°C. Following incubation with horseradish peroxidase conjugated antimouse IgG (GE Healthcare, Tokyo, Japan) for 1 h at room temperature, cyclin B1 was detected using SuperSignal West Pico (Pierce, Rockford, IL). After removal of antibodies from the membranes by Re-Blot Western Blot Recycling Kit (Chemicon, Temecula, CA), immunoblotting were repeated using anti-β-actin monoclonal antibody (Sigma) as described above to normalize the total amount of protein loaded per well. The relative absorbance of band intensities was determined by densitometric analyses (GeneTools; Syngene, Frederick, MD).
In vitro maturation, fertilization, and early embryonic development
To assess the effect of GDNF on the cytoplasmic maturation of preovulatory oocytes, and a potential complementary roles of BDNF on GDNF actions, we performed in vitro maturation of oocytes followed by in vitro fertilization as described (Kawamura et al., 2005c) . COCs from PMSG-primed mice were obtained in the M2 medium supplemented with 0.1% FBS before culturing in minimum essential media (Invitrogen) supplemented with Earle's salts, 10 μg/ ml streptomycin sulfate, 75 μg/ml penicillin G, and 0.1% FBS in the presence or absence of 30 ng/ml GDNF, 0.1 ng/ml BDNF, or 30 ng/ml GDNF together with 0.03 or 0.1 ng/ml BDNF at 37°C in 5% CO 2 /95% air. The doses of BDNF were chosen from the highest concentrations that did not affect on either nuclear or cytoplasmic maturation of oocytes when cultured with BDNF alone. After 17 h of treatment, cumulus cells were removed and the oocytes were examined and classified according to their developmental stages (GV, MI, or MII). MII oocytes were inseminated with sperm from B6D2F1 males and incubated for 6 h at 37°C in 5% CO 2 /95% air. After in vitro fertilization, fertilized oocytes were recovered, washed twice, and cultured in human tubal fluid medium (Chemicon). Twenty-two hours after insemination, two-cell-stage embryos were collected and cultured in 50 μl drops of M16 medium for 5 more days up to the blastocyst stage. Embryonic development was monitored daily under the Hoffman modulation contrast microscopy, and the progression of fertilized eggs to preimplantation embryos was assessed.
Embryo cultures and apoptosis detection
Two-cell-stage embryos were obtained and groups of 10-12 embryos were placed in 50 μl drops of M16 medium with or without GDNF and covered by mineral oil. Embryos were cultured for 96 h up to the hatched blastocyst stage with fresh medium replacement every 24 h. Some embryos were cultured with or without GDNF in the absence or presence of the neutralizing anti-GDNF antibody or nonimmune goat IgG. To examine effects of endogenously produced GDNF on early embryonic development and survival, groups of 40-45 embryos were cultured in 10 μl drops of M16 medium with or without the neutralizing anti-GDNF antibody or nonimmune goat IgG. Embryonic development was monitored after 24, 72, and 96 h of culture to determine the proportion of embryos at morula, expanded blastocyst, and hatched blastocyst stages, respectively. At the end of culture, some embryos were subjected to the TUNEL assay to detect apoptosis as described (Kawamura et al., 2005b) .
Evaluation of cell numbers in inner cell mass and trophectoderm
To examine the preferential effect of GDNF on specific cell lineages in blastocysts, the numbers of inner cell mass and trophectoderm cells in blastocysts were counted by the differential labeling technique using two polynucleotide-specific fluorochromes (Kawamura et al., 2003) . After staining, the blastocysts were mounted on a glass slide, and the number of cells in the inner cell mass and trophectoderm cells in each blastocyst was counted under an epifluorescence microscope (Olympus Corp., Tokyo, Japan).
Statistical analysis
Statistical analysis was carried out by using Mann-Whitney U test for paired comparison and the one-way ANOVA followed by Fisher's protected least significant difference for multiple group comparison. Results are presented as mean ± SEM of at least three separate experiments.
Results
Gonadotropin stimulation of the ovarian expression of GDNF and its receptor Gfra1
We used DNA microarray analyses to identify ovarian paracrine ligands induced by LH/hCG during the preovulatory period. As shown in Figs. 1A and B (line graphs), the expressions of both Gdnf and Gfra1 mRNAs were stimulated after treatment with Pregnyl containing hCG activity. To confirm DNA microarray results, we performed real-time RT-PCR of ovarian transcripts for these genes in mice treated with PMSG followed by an i.p. injection of an ovulatory dose of hCG 48 h later. In addition to demonstrating preovulatory increases in both Gdnf and Gfra1 transcripts in whole ovaries (Figs. 1A and B, bar graphs) , the stimulatory effect of hCG/ Pregnyl on ovarian GDNF proteins was detected using ELISA (Fig. 1C) . Treatment with hCG increased more than 2-fold ovarian GDNF antigen levels at 4 h after hormonal treatment, followed by a gradual decline.
Ovarian cell types expressing GDNF and the hCG stimulation of Gdnf and Gfra1 expressions in isolated ovarian cells
The localization of GDNF protein was determined by using immunohistochemistry. As shown in Fig. 2A , GDNF staining was observed in cumulus, mural granulosa, and theca cells, but not in oocytes of preovulatory follicles at 4 h after hCG treatment. In addition, small antral follicles were not stained with GDNF ( Fig. 2A) . In mural granulosa cells, the GDNF signal was detected in cells surrounding the antrum cavity ( Fig. 2A) .
Using isolated ovarian cells, we also examined the regulation of Gdnf, Gfra1, and Ret transcript levels after hCG treatment by real-time RT-PCR (Fig. 2B) . Although clear stimulation of Gdnf mRNA was found in cumulus and mural granulosa cells, levels of this transcript were negligible in oocytes (Fig. 2B) . In contrast, the Gfra1 mRNA was predominantly expressed in oocytes and cumulus cells from mice primed with PMSG for 48 h (Fig. 2B) . After hCG treatment, the Gfra1 transcript level was increased in both cumulus cells and mural granulosa cells, whereas the Gfra1 transcript level remained stable in oocytes (Fig. 2B) . The Ret mRNA showed the highest levels in cumulus cells at 48 h after PMSG treatment among tested cell types with low levels in the granulosa cells (Fig. 2B) . After hCG treatment, Ret transcript levels were increased in both cumulus and mural granulosa cells, but stable in oocytes (Fig. 2B) .
Effects of GDNF on the nuclear maturation of preovulatory oocytes
Based on the hCG stimulation of GDNF expression in ovarian somatic cells and the expression of GFRA1 and Ret in oocytes, we tested if GDNF acts as a paracrine factor to regulate oocyte functions. Because oocytes obtained from preovulatory follicles underwent spontaneous GVBD when cultured as COC, we used the preovulatory follicle culture to test the effect of GDNF on GVBD in oocytes. In cultured preovulatory follicles, treatment with LH, but not GDNF, for 8 h induced GVBD in oocytes (Fig. 3A) . Furthermore, treatment with GDNF, unlike LH, did not induce cumulus cell expansion (data not shown). Because preovulatory follicles are difficult to culture for a prolonged time, we used the COC model to test the effect of GDNF in promoting further development of oocytes. As shown in Fig. 3B , treatment with GDNF increased first polar body extrusion of oocytes in cultured COCs in a dose-dependent manner. Similar stimulation was evident when DOs were treated with GDNF (Fig. 3C) , indicating a direct effect of GDNF on oocyte receptors. In addition, the stimulatory effect of GDNF in the COC model was blocked by cotreatment with the neutralizing anti-GDNF antibody (Fig. 3D ), but not with the nonimmune IgG.
Furthermore, treatment with the neutralizing anti-GDNF antibody alone was ineffective. We further assessed the molecular mechanism underlying the GDNF promotion of first polar body extrusion. Because MI phase lasted between 7 and 10 h during in vitro culture in the oocytes (data not shown), COCs obtained from preovulatory follicles were cultured for 7 h before measuring the levels of cyclin B1 proteins in oocytes at MI phase. Although a 60-kDa antigen corresponding to cyclin B1 was detected in all samples, its levels were increased 2.5-fold by treatment with GDNF treatment (Fig. 3E) .
To explore whether BDNF and GDNF complement each other in the control of first polar body extrusion, COCs were cultured with either GDNF or BDNF alone or with GDNF in the presence of BDNF. Although treatment with GDNF or BDNF alone promoted first polar body extrusion, the proportion of first polar body extrusion in the group cotreated with GDNF and BDNF was similar to that treated with BDNF alone (Fig. 3F) , suggesting redundant roles of GDNF and BDNF in first polar body extrusion.
Effects of GDNF on cytoplasmic maturation
The role of GDNF in conditioning the oocytes for subsequent fertilization and progression to blastocysts was evaluated in vitro (Fig. 4A) . COCs obtained from mice primed for 48 h with PMSG were cultured with or without GDNF. To avoid hardening of the zona pellucida that is unfavorable for in vitro fertilization, 0.1% FBS was included for all cultures. Similar to serum-free cultures (Fig. 3B) , treatment with GDNF increased the proportion of oocytes showing first polar body extrusion (Fig. 4A , MII oocytes). These MII oocytes were then fertilized in vitro without further treatment with GDNF. However, pretreatment with GDNF did not increase the proportions of MII oocytes that developed into the two-cell or blastocyst-stage embryos (Fig. 4A ). Furthermore, we tested if GDNF stimulates cytoplasmic maturation of oocytes in the presence of low levels of BDNF. As shown in Fig. 4B , supplementation of GDNF with low levels of BDNF had no effect on cytoplasmic maturation, or on the GDNF-promoted first polar body extrusion.
Temporal and spatial expression of GDNF and its receptors, Gfra1 and Ret in preimplantation embryos
To gain a more complete understanding of the roles of GDNF and its receptors during early embryonic development, we further tested the expression of these genes in early embryos. Quantitative real-time RT-PCR was performed to examine the temporal expression of Gdnf as well as Gfra1 and Ret receptors in preimplantation embryos. Levels of Gdnf mRNA were low from the two-cell stage up to the Fig. 2 . Localization of GDNF in mouse ovaries and its stimulation by hCG in the cumulus, granulosa, and theca cells. (A) Immunohistochemical detection of GDNF in ovaries of PMSG-primed mice 4 h after hCG injection. GDNF was found in cumulus (black arrowheads), mural granulosa (white arrowheads), and theca cells (arrows) of preovulatory follicles. Two lower panels depict sections with nonimmune IgG and serve as controls. (Scale bars, 200 μm.) (B) hCG regulation of Gdnf, Gfra1, and Ret expression in mouse oocytes (OC), cumulus cells (CC), and mural granulosa cells (GC) at different times after hCG treatment. Transcript levels of Gdnf, Gfra1, and Ret in isolated ovarian cells were quantified by real-time RT-PCR (mean ± SEM, n = 5). For each time point, five samples prepared from individual animals were used. *P b 0.01 vs. 0 h of hCG treatment. morula stage, but increased at the blastocyst stage, and reaching its highest levels in the hatched blastocyst stage (Fig. 5A, upper panel) . In contrast, levels of Gfra1 mRNA were high in the two-cell-stage embryos and showed a decrease in the eight-cell stage before increasing at the morula stage to reach the highest levels in the hatched blastocyst stage (Fig. 5A, middle panel) . The temporal expression of Ret mRNA in preimplantation embryos was Fig. 3 . GDNF stimulation of first polar body extrusion by cultured preovulatory oocytes. (A) Lack of effects of GDNF on GVBD of oocytes. Preovulatory follicles were cultured without (control, C) or with LH (5 μg/ml) or GDNF (30-1000 ng/ml) for 8 h before evaluation of oocytes undergoing GVBD (n = 3, 61-69 follicles per experimental group). (B and C) Effects of GDNF treatment on first polar body extrusion by cultured cumulus-oocyte complexes (B; COCs) and denuded oocytes (C; DOs). COCs or denuded oocytes isolated from preovulatory follicles were cultured without (controls, C) or with GDNF for 24 h. After culture, the percentage of oocytes showing first polar body extrusion was determined (n ≥ 3, 48-186 oocytes per experimental group). (D) Neutralizing effects of the anti-GDNF antibody on the GDNF stimulation of first polar body extrusion. COCs were cultured with or without GDNF (30 ng/ml) in the absence or presence of the anti-GDNF antibody or nonimmune IgG (n ≥ 3, 35-186 oocytes per experimental group). (E) Effects of GDNF treatment on the levels of cyclin B1 protein in MI oocytes. COCs were cultured without (controls, C) or with GDNF for 7 h. After removal of cumulus cells, oocytes were subjected to immunoblotting. The cyclin B1 levels were represented as fold increases to the control group (mean ± SEM, n = 3). (F) Effects of BDNF treatment on the GDNF-promoted first polar body extrusion. COCs were cultured without (controls, C) or with GDNF (30 ng/ml), BDNF (3 ng/ml) or GDNF (30 ng/ml) in the presence of BDNF (3 ng/ml) (n ≥ 3, 72-140 oocytes per experimental group). *, P b 0.01 vs. control group. similar to that of Gdnf, showing increases in the blastocyst stages (Fig. 5A, lower panel) .
Cells in the inner cell mass and trophectoderm were isolated for RT-PCR analyses to determine the cell types expressing Gdnf, Gfra1, and Ret in blastocysts. The Gdnf and Gfra1 transcripts were detected in trophectoderm cells, but not cells in the inner cell mass. In contrast, Ret mRNA was expressed both cell lineages (Fig. 5B) . The purity of isolated cells was confirmed by using Oct-4 and uPA as markers for the inner cell mass and trophectoderm, respectively. The expression of GDNF in trophectoderm cells was further confirmed using immunofluorescent staining (Fig. 5C ).
Expression of GDNF in oviducts and uteri during the preimplantation period
The expression of GDNF in oviducts and uteri was examined during the preimplantation period. In the oviducts, quantitative real-time RT-PCR analyses indicated that Gdnf mRNA levels were high in immature mice at 25 days of age (Fig. 6A, 0 h ), decreased after PMSG treatment, and maintained at low levels until 12 h after hCG treatment (Fig. 6A) . However, Gdnf mRNA levels increased at days 2 and 4 of pregnancy (Fig. 6A) . In the uterus, levels of GDNF transcripts were high in immature mice at 25 days of age (Fig. 6B, 0 h ), and decreased after PMSG treatment, and maintained at similar levels from 12 h after hCG treatment until day 4 of pregnancy ( Fig. 6B) . Immunohistochemical analyses further indicated that GDNF were expressed in the oviductal epithelial cells and the luminal and glandular epitheliums of uterine endometrium, but not in stromal cells (Fig. 6C , upper and middle, GDNF staining; lower, negative controls).
Effects of GDNF treatment on the development of preimplantation embryos
The expression of GDNF, GFRA1, and Ret in preimplantation embryos and the production of GDNF in oviduct and uteri suggest the GDNF/GFRA1-Ret signaling system could play a role during early embryonic development. We further tested the effect of GDNF treatment on cultured early embryos. Although GDNF treatment did not affect the development of two-cellstage embryos to the morula stage (data not shown), GDNF promoted the development of embryos to the expanded and hatched blastocyst stages evaluated after 72 and 96 h of culture, respectively (Fig. 7A) . The specificity of the effects of GDNF on preimplantation embryos was examined by using the Fig. 4 . Lack of effect of GDNF in the conditioning of oocytes for the development into preimplantation embryos. (A) Lack of effect of GDNF on cytoplasmic maturation of preovulatory oocytes. COCs obtained from preovulatory follicles were cultured without (control) or with GDNF (30 ng/ml) for 17 h. After progression into the MII stage, oocytes were inseminated and cultured for 5 more days without hormones. The percentage of MII oocytes developing into 2-cell-stage embryos and the percentage of 2-cell-stage embryos developing into blastocyst-stage embryos were evaluated (n = 4, 97-166 oocytes per experimental group). (B) Lack of effect of GDNF on cytoplasmic maturation of preovulatory oocytes in the presence of low levels of BDNF. COCs were cultured without or with GDNF (30 ng/ml), BDNF (0.1 ng/ml) or GDNF (30 ng/ml) in the presence of BDNF (0.03 or 0.1 ng/ml) (n ≥ 3, 60-166 oocytes per experimental group). *P b 0.01 vs. controls. neutralizing anti-GDNF antibody. The ability of GDNF to promote the development of two-cell-stage embryos to the hatched blastocyst stage was blocked by cotreatment with the neutralizing anti-GDNF antibody, but not with the nonimmune IgG (Fig. 7B) .
To examine the effect of endogenous GDNF on embryo development, embryos were cultured at a higher density to increase the concentration of endogenous GDNF in the culture medium, and the embryos were treated with the neutralizing anti-GDNF antibody or the nonimmue IgG alone without GDNF. Although the proportions of embryos at the hatched blastocyst stage in the control group were increased following culture at high density, treatment with the neutralizing anti-GDNF antibody did not affect on the development of embryos (control, 75.4 ± 4.2%; anti-GDNF antibody, 72.2 ± 5.0%; nonimmue IgG, 71.1 ± 4.2%).
Effects of GDNF treatment on cell proliferation and apoptosis of cultured blastocysts
To determine if GDNF acts as a survival factor for early embryos, we evaluated cell proliferation and apoptosis in cultured embryos treated with GDNF. Two-cell-stage embryos were cultured for 72 h with GDNF. Because hatched blastocysts are difficult to retrieve due to extreme viscosity, expanded blastocysts were used for TUNEL staining. Counting of cells indicated that GDNF treatment increased the total number of cells in blastocysts (Figs. 8A and C) , and the increase of cell number was preferentially observed in the trophectoderm (Fig.  8C) . Treatment with GDNF also decreased the proportion of TUNEL-positive nuclei (Fig. 8B) , thus suggesting a suppression of apoptosis. Furthermore, the effects of GDNF on cell Fig. 6 . Expression of GDNF in mouse oviducts and uteri during the preimplantation period. Quantification of Gdnf transcripts in oviducts (A) and uteri (B) using realtime RT-PCR. Levels of Gdnf mRNA were obtained at different times after PMSG and hCG treatment. Some samples were obtained from animals at days 2 or 4 of pregnancy (mean ± SEM, n = 3). For each stage, three samples prepared from individual animals were used. Levels of Gdnf mRNA were normalized using transcript levels of histone H2a in the same sample. *P b 0.01 vs. oviducts from animals treated with PMSG for 48 h and uteri from animals primed with PMSG followed by hCG treatment for 12 h. number and apoptosis were blocked by cotreatment with the neutralizing anti-GDNF antibody, but not with the nonimmue IgG (Fig. 8B) . Similar to studies on early embryonic development, treatment with the neutralizing anti-GDNF antibody alone had no effect on the numbers of cells and TUNELpositive nuclei in the blastocysts cultured at high density without GDNF (cell number: control, 101.3 ± 3.9; anti-GDNF antibody, 106.3 ± 5.6; nonimmue IgG, 105.2 ± 6.2, TUNELpositive nuclei: control, 2.37 ± 0.38%; anti-GDNF antibody, 2.19 ± 0.32%; nonimmue IgG, 2.33 ± 0.48%).
Discussion
The present study demonstrates the important role of an ovarian paracrine factor, GDNF, in stimulating first polar body extrusion. Mammalian oocytes undergo spontaneous GVBD after removal from surrounding somatic cells, but only a fraction of them reach the first polar body stage. Although earlier studies demonstrated the important roles of ovarian EGFlike factors and INSL3 in GVBD during the preovulatory period (Kawamura et al., 2004; Park et al., 2004) , these factors are not needed for nuclear envelope breakdown of isolated oocytes during in vitro culture. In contrast, our previous (Kawamura et al., 2005c ) and the present findings demonstrated that both BDNF and GDNF are capable of promoting first polar body extrusion, and their redundant roles in first polar body extrusion. Although the proportion of spontaneous first polar body extrusion is different among the mouse strains (Marin Bivens et al., 2004) , GDNF also promoted first polar body extrusion in Jcl:ICR strain that showed high spontaneous levels of first polar body extrusion (control, 61.9 ± 3.1%; 30 ng/ml GDNF, 78.0 ± 5.1%). However, the effects of GDNF were more evident in the BDF1 mice. Mouse oocytes do not require de novo synthesis of proteins to undergo GVBD in vitro, whereas the synthesis of cyclin B1 is indispensable for the progression of meiotic maturation after GVBD (Hampl and Eppig, 1995; Polanski et al., 1998) . Thus, our data on the increase in cyclin B1 protein in MI oocytes following GDNF treatment suggest its contribution to the GDNF promotion of completion of meiosis I. Although BDNF could condition the eggs for optimal fertilization and development into preimplantation embryos (Kawamura et al., 2005c) , ovarian GDNF showed no effect on the cytoplasmic maturation of preovulatory oocytes in the present model. A recent study reported that the proportion of parthenogenetically activated porcine oocytes forming blastocyst was increased after in vitro culture with GDNF (Linher et al., 2007) . In contrast to our experimental setting for oocyte maturation, LH, FSH, EGF, and 10% porcine follicular fluid were included in the maturation medium of this study. Thus, GDNF may require additional hormonal factors and/or unknown factors present in the follicular fluid for the optimal induction of the cytoplasmic maturation of oocytes. However, the low levels of BDNF did not augment GDNF-stimulated cytoplasmic maturation.
DNA microarray analyses of the ovarian transcriptome during the preovulatory period allowed us to identify major stimulation of both GDNF and GFRA1 expressions after the LH/hCG induction of ovulation. Our findings of presence of ovarian GDNF in mice are consistent with earlier studies in rodents (Choi-Lundberg and Bohn, 1995; Golden et al., 1999; Widenfalk et al., 2000) . Ovarian localization of GDNF, GFRA1 and Ret genes, their regulation by hCG and earlier findings of GDNF proteins in porcine follicular fluid (Linher et al., 2007) suggested that GDNF produced by ovarian somatic cells in response to hCG stimuli could act on the GFRA1-Ret receptor complex that is expressed in the oocyte. Because both GDNF and its receptors, GFRA1 and Ret, are also expressed in the cumulus and granulosa cells, their autocrine/paracrine roles in the cumulus and granulosa cells cannot be ruled out.
Completion of the nuclear maturation of oocytes involves GVBD and extrusion of the first polar body. Although treatment of cultured COCs with GDNF did not affect GVBD of oocytes, it facilitated first polar body extrusion, consistent with an earlier finding in porcine (Linher et al., 2007) . The dose range used in the present studies was similar to that used in the porcine study (Linher et al., 2007) . Furthermore, the concentrations of GDNF in human preovulatory follicular fluid were comparable to those levels. Similar to the BDNF stimulation of first polar body extrusion, but not GVBD, it is apparent that sequential steps of nuclear maturation of the oocyte are controlled by different paracrine factors. Although both cumulus cells and oocytes in COCs express GFRA1 and Ret receptors, GDNF induced first polar body extrusion in denuded oocytes, suggesting its direct effects on oocytes. Our unpublished data showed that GDNF treatment did not induce cumulus cell expansion in preovulatory follicles cultured with the serum-free medium. Because a recent study demonstrated GDNF induction of cumulus cell expansion of COCs cultured in the medium containing LH, FSH, EGF, and 10% porcine follicular fluid (Linher et al., 2007) , GDNF may support cumulus cell expansion in combination with other factors.
Our data further showed the expression of Gfra1 and Ret receptor mRNAs not only in oocytes but also in preimplantation embryos, and the production of GDNF in the oviductal and uterine epitheliums. Because preimplantation embryos develop in the oviduct until day 4 of pregnancy when they reach the late morula/blastocyst stage before migrating to the uterus, the increasing levels of GDNF in the oviduct and uterus during days 2 and 4 of pregnancy suggest potential paracrine roles of GDNF in preimplantation embryo development. In cultured preimplantation embryos, the present study further demonstrated the ability of GDNF to promote early embryonic development and to suppress embryo cell apoptosis, suggesting the inclusion of this factor could promote in vitro embryo cultures.
The effect of GDNF to promote blastocyst development is associated with its ability to inhibit apoptosis and to increase total cell numbers in blastocysts. Both GFRA1 and the coreceptor are highly expressed in trophectoderm cells of Fig. 8 . Treatment with GDNF increases cell numbers and suppresses apoptosis in blastocysts. Effects of GDNF treatment on cell number (A) and apoptosis (B) in blastocysts. Two-cell-stage embryos were cultured for 72 h with or without GDNF (10 ng/ml) and the specificity of GDNF actions was evaluated by cotreatment with the anti-GDNF antibody (1 μg/ml). Apoptosis in embryos was assayed by detecting apoptotic nuclei using TUNEL staining (mean ± SEM, total n = 20 embryos per group). (C) Effects of GDNF treatment on the number of total, TE, and ICM cells in blastocysts. Two-cell-stage embryos were cultured for 72 h with or without GDNF (10 ng/ml) (mean ± SEM, total n = 20 embryos per group.) *P b 0.01 vs. control group. expanded and hatched blastocysts. GDNF likely acts through these receptors to promote early embryonic development, to increase cell numbers in blastocyst, and to prevent blastocyst cell apoptosis. The apoptosis-suppressing effect of GDNF is consistent with earlier studies showing the survival actions of GDNF on neuronal cells (Airaksinen and Saarma, 2002; Lin et al., 1993) . For example, there is a substantial loss of motor neurons, and a corresponding increase in apoptotic cells, in GDNF-and GFRA1-deficient mouse embryos (Garces et al., 2000) . Conversely, motor neuron survival is promoted by overexpression of GDNF or GDNF treatment in utero (Oppenheim et al., 2000) . GDNF also promotes the migration, proliferation, survival and differentiation of multipotent precursor cells of enteric nervous system that express GFRA1 and Ret (Taraviras et al., 1999) . The observed exclusive expression of GFRA1 in trophectoderm cells of blastocysts is consistent with our findings of a preferential effect of GDNF on the cell proliferation of trophectoderm cells. Because trophectoderm cells in blastocysts differentiate during embryonic development to form the invasive trophoblasts that mediate embryo implantation into the uterine wall, our findings suggest a potential involvement of GDNF during implantation.
In addition to the paracrine signaling of GDNF, endogenous GDNF is also expressed in the trophectoderm cells of blastocysts. Because the concentration of endogenous hormonal ligands in the culture medium are higher when embryos are cultured at high density (Paria and Dey, 1990) , the autocrine roles of GDNF during early embryonic development could be demonstrated in embryos cultured at high density by treatment with the neutralizing anti-GDNF antibody without exogenous GDNF. However, we could not demonstrate stimulating effects of endogenous GDNF in the embryo development. Because of the low expression levels of GDNF in the embryos, the concentration of endogenous GDNF was too low to exhibit its effects on the embryo development. Thus, in contrast to the paracrine effects, autocrine roles of GDNF in early embryonic development may be less important in physiological conditions.
Because mutant mice with defects in GDNF, GFRA1, or Ret showed similar phenotypes and died at first postnatal day (Enomoto et al., 1998; Moore et al., 1996; Pichel et al., 1996; Schuchardt et al., 1994) , no female mice were available for investigating changes in ovarian functions. GDNF preferentially interacts with the receptor complex GFRA1-Ret, but it can also activate the GFRA2-Ret complex. Although GFRA1 binds GDNF with high affinity, it also interacts with other GDNF family members including neurturin and artemin (Saarma and Sariola, 1999) . Because our preliminary data indicated the expression of Gfra2 transcripts in preimplantation embryos, and both neurturin and artemin expressions in oviducts and uteri (data not shown), studies on the role of GDNF during early embryonic development in pups lacking GFRA1 are complicated due to the overlapping actions of different GDNF family members and their receptor complexes.
Herein, we have demonstrated the ability of GDNF to complete meiosis I of preovulatory oocytes and to enhance the development and survival of preimplantation embryos. It is becoming clear that this ligand signaling system, originally found to be essential for the survival and differentiation of the neuronal system, is also important for diverse reproductive processes including the spermatogonial self-renewal and differentiation (Meng et al., 2000) , the cumulus cell expansion (Linher et al., 2007) , the nuclear and cytoplasmic maturation of oocytes (Linher et al., 2007) , and the development of early embryos. The present demonstration of an augmenting role for GDNF in the development of oocytes and early embryos underscores the importance of diverse autocrine/paracrine systems for oocyte maturation and early embryogenesis. Understanding of these intercellular communication networks could lead to new approaches in the treatment of infertility, and facilitate future formulation for the optimal culture conditions for in vitro maturation, in vitro fertilization and embryonic stem cell derivation.
